Mechanisms of drug-induced liver injury: from bedside to bench. - Wikidata - awgldk - TriplyDB

Mechanisms of drug-induced liver injury: from bedside to bench.

Mechanisms of drug-induced liver injury: from bedside to bench.

http://www.wikidata.org/entity/Q34169362

about

The Need for Biomarkers in Diagnosis and Prognosis of Drug-Induced Liver Disease: Does Metabolomics Have Any Role?Biomarker-based drug safety assessment in the age of systems pharmacology: from foundational to regulatory science Cellular imaging: a key phenotypic screening strategy for predictive toxicology Novel in vitro and mathematical models for the prediction of chemical toxicity Engineering liver Drug-induced hepatotoxicity: metabolic, genetic and immunological basis Drug allergy: causes and desensitization Identification of novel translational urinary biomarkers for acetaminophen-induced acute liver injury using proteomic profiling in mice Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance Drug-induced liver injury: recent advances in diagnosis and risk assessment.Acute liver injury in a patient with alcohol dependence: a case resembling autoimmune hepatitis or drug-induced liver injury Exploration of Biomarkers for Amoxicillin/Clavulanate-Induced Liver Injury: Multi-Omics Approaches.Long-term culture of human liver tissue with advanced hepatic functions.Relationship between characteristics of medications and drug-induced liver disease phenotype and outcome.The Effects of Melatonin on Elevated Liver Enzymes during Statin Treatment.Hepatocellular Toxicity Associated with Tyrosine Kinase Inhibitors: Mitochondrial Damage and Inhibition of Glycolysis.In vitro platforms for evaluating liver toxicity.Pregnane X receptor and drug-induced liver injury.An open label pilot study to evaluate the efficacy of Spanish black radish on the induction of phase I and phase II enzymes in healthy male subjects Proteomic profiling in incubation medium of mouse, rat and human precision-cut liver slices for biomarker detection regarding acute drug-induced liver injury.Liraglutide-induced autoimmune hepatitis Moderate activation of IKK2-NF-kB in unstressed adult mouse liver induces cytoprotective genes and lipogenesis without apparent signs of inflammation or fibrosis.Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies.A multicenter assessment of single-cell models aligned to standard measures of cell health for prediction of acute hepatotoxicity Cytotoxic Synergy Between Cytokines and NSAIDs Associated With Idiosyncratic Hepatotoxicity Is Driven by Mitogen-Activated Protein Kinases Aneuploidy as a mechanism for stress-induced liver adaptation.Identification of Identical Transcript Changes in Liver and Whole Blood during Acetaminophen Toxicity.Detection of nanolevel drug metabolites in an organotypic culture of primary human hepatocytes and porcine hepatocytes with special reference to a two-compartment model.Parkin and mitofusins reciprocally regulate mitophagy and mitochondrial spheroid formation.Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure.A case of acute liver failure due to etodolac A Novel Resolvin-Based Strategy for Limiting Acetaminophen Hepatotoxicity.Serum proteomic profiling in patients with drug-induced liver injury.DILI: New Insights into Diagnosis and Management.Subtoxic Alterations in Hepatocyte-Derived Exosomes: An Early Step in Drug-Induced Liver Injury?Ferulic acid attenuated acetaminophen-induced hepatotoxicity though down-regulating the cytochrome P 2E1 and inhibiting toll-like receptor 4 signaling-mediated inflammation in mice.Metronidazole induced liver injury: a rare immune mediated drug reaction.Efficacy and safety of danoprevir-ritonavir plus peginterferon alfa-2a-ribavirin in hepatitis C virus genotype 1 prior null responders.Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays.

P2860

Q26772999-CEC5583B-612C-43A2-A0C6-D2EE4C01F720 Q26778374-AF71DFA6-8438-4309-A2CF-7109BA3EE801 Q26781577-0A768BEB-3A53-4074-9E40-FEFE09002477 Q26851492-D69D995B-5D96-477D-881B-48D155ADA089 Q26864348-CD143BB4-5463-464F-A4C6-1EEFBB40C697 Q26991809-8E14531A-FE97-4329-9420-DBE27E66BCD1 Q27012238-3267F2B7-CE24-422E-B3D0-128863F4CF99 Q28485164-CFB25669-B3B8-4EF1-84B5-BA4E67C1BA7A Q28538041-3D609EB7-3937-463B-97A8-CC10DDD7F22C Q30235089-ADAB2781-6CB1-4A96-8E1B-4ECB986FA363 Q33628364-408FBBBA-C8BD-41DE-BD44-9262B6C6D911 Q33648066-516C1551-FA3D-4003-AE7B-B38AA6B6FFB3 Q33752322-575DDF7A-030A-4B6F-9E36-6EBC0C24B4FB Q33784830-A4EB6F88-7819-460A-899A-ECE7731215A1 Q33786661-64789C4B-7524-4BCE-A88C-B3706517A1A7 Q33794548-787E3901-D48C-42FA-8082-F92ADAF5C445 Q34143314-AAF4CF36-9D5C-420B-997E-E09F495D6144 Q34345049-A86E2C99-A777-42CA-9E3D-48EBFAF3D3F9 Q34968588-5AEAFA54-4CE7-4448-B9C4-0CEFCB9AC62D Q34987732-FDCF5050-80C7-45FD-9C32-47B99EDFF64C Q35580550-E78410F0-C54C-44A6-BBE2-E60BDC6634E0 Q35721070-2B51EC97-A82A-4053-B990-0B57D582C324 Q35826421-0E235DBA-2C2B-40E1-AE1E-135EB7733916 Q36061736-D24D357A-E9CE-4888-8A65-2A0BED7C2E0E Q36167548-7603F88D-9E89-40F2-A17C-F01FD5F985B4 Q36190750-A44D09BB-EC0D-469A-9497-9DC101C54DDE Q36206111-D94E8C95-632C-4DF6-90C4-151EC973687A Q36440758-FB43E612-9629-4391-984A-24165EDEFCEB Q36452057-47276C22-D5B4-4B2B-B7DE-4FE1CCD4F71F Q36669589-15A5E2E6-9A8D-4EE5-969B-27FE43E1BEF4 Q36720833-531DE33A-4F90-4E11-B4A5-3E3D2BEA533A Q36729997-E5085E85-98AE-4EFE-B9D7-605C06C98BEB Q36768943-CE013683-C12C-409D-8EC0-525F026B1CCD Q36845657-F7623EFE-76DF-4DD7-B78B-AF9702FCCBB2 Q36885006-E0F12BE3-902D-4827-AE6A-53B59FF8CD82 Q36935435-4AE8E14E-040F-4753-9A94-6EE306CF0368 Q37393416-B9377B21-F6BC-45AC-9079-BBE181BFB4FC Q37449762-613B4D2D-5A4F-452F-B3CF-33D717204855 Q37544611-25CCB4F9-87E2-4F0F-8271-CF4C00CF4DF9 Q37590883-3147E19B-42F6-447A-B168-F438834EF8D3

P2860

Mechanisms of drug-induced liver injury: from bedside to bench.

http://www.wikidata.org/entity/Q34169362

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Mechanisms of drug-induced liver injury: from bedside to bench.

@ast

Mechanisms of drug-induced liver injury: from bedside to bench.

@en

Mechanisms of drug-induced liver injury: from bedside to bench.

@nl

type

label

Mechanisms of drug-induced liver injury: from bedside to bench.

@ast

Mechanisms of drug-induced liver injury: from bedside to bench.

@en

Mechanisms of drug-induced liver injury: from bedside to bench.

@nl

prefLabel

Mechanisms of drug-induced liver injury: from bedside to bench.

@ast

Mechanisms of drug-induced liver injury: from bedside to bench.

@en

Mechanisms of drug-induced liver injury: from bedside to bench.

@nl

P1433

Q34169362-22EAA547-919C-4133-B2D8-7A308193451B

P1476

Q34169362-AEB70C87-34AC-40EA-9494-450B1565A78D

P2093

Q34169362-935081F7-D68A-44B9-86B1-1F74A1168B6B

Q34169362-D6E379B8-5518-4452-83F1-52BF6C954009

P2860

Q34169362-0065093C-68D7-4C34-B463-38FAF35B7B27

Q34169362-0659B41A-2DC0-4D7C-BA6D-64E4C397C232

Q34169362-0E860A61-7F77-4DC5-AC15-46F7E8970401

Q34169362-0FDCC840-6AFF-4025-B85E-A23749A05DA2

Q34169362-11189F1F-A62B-4DDB-9442-06C3B6D8B8AC

Q34169362-1715F0B5-B96F-405D-AB9D-9501E93BC7C7

Q34169362-1B74687D-1CE0-4759-80DD-E3B5509D925C

Q34169362-1C92A629-5334-45B4-B0FB-0371997246C1

Q34169362-1EEF049E-3D39-424B-A06C-505216FE80C8

Q34169362-3647F572-3E8A-4AFE-B287-C50B3B81F7F0

P2888

Q34169362-155BB074-BB7A-4DB7-8699-582E5FD1233A

P304

Q34169362-4833AEAF-0FB5-4ADC-B4D4-13D1214811B0

P31

Q34169362-265A9256-BCE5-4CB0-84D0-09BA0C4363CC

P356

Q34169362-BC7EF448-4FC4-477C-BD5B-D9880D3C5ED8

P407

Q34169362-CE4BB821-2D2A-4D1E-905F-781CC290DF72

P433

Q34169362-5A3018DC-CDC2-43EC-BDD0-ADC5612BAD39

P478

Q34169362-40A68C0B-E8F7-499F-A0B8-6B0E0249359A

P577

Q34169362-25840163-1BE2-4C13-AAEE-2056EE516FAD

P698

Q34169362-26060C73-AE73-46AB-B172-04FDC6C5F9AE

P356

NRGASTRO.2011.22

P1433

Nature Reviews Gastroenterology & Hepatology

P1476

Mechanisms of drug-induced liver injury: from bedside to bench.

@en

P2093

Robert J Fontana

http://www.w3.org/2001/XMLSchema#string

Shannan Tujios

http://www.w3.org/2001/XMLSchema#string

P2860

Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome

HLA association of amoxicillin-clavulanate--induced hepatitis

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.

Valproic acid hepatic fatalities. III. U.S. experience since 1986.

Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome.

Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver.

Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity.

Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.

Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.

P2888

nrgastro.2011.22

P304

202-211

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRGASTRO.2011.22

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21386809

http://www.w3.org/2001/XMLSchema#string